Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:823-828

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woodcock, E. A.
Right arrow Articles by Du, X.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woodcock, E. A.
Right arrow Articles by Du, X.-J.
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Arrythmias-basic studies
Right arrow Other Vascular biology

(Circulation. 1999;99:823-828.)
© 1999 American Heart Association, Inc.


Basic Science Reports

Inhibition of Inositol(1,4,5)Trisphosphate Generation by Endothelin-1 During Postischemic Reperfusion

A Novel Antiarrhythmic Mechanism

Elizabeth A. Woodcock, PhD; Nancy Reyes, Dipl Biol Sci; Alexander N. Jacobsen, MBBS; Xiao-Jun Du, MB, PhD

From the Cellular Biochemistry Laboratory and the Experimental Cardiology Laboratory (X.-J.D.), Baker Medical Research Institute, Prahran, Victoria, Australia.

Correspondence to Dr E.A. Woodcock, Baker Medical Research Institute, PO Box 6492, Melbourne 8008, Victoria, Australia. E-mail liz.woodcock{at}baker.edu.au

Background—Reperfusion of ischemic rat hearts in the presence of thrombin or norepinephrine but not endothelin-1 causes the generation of inositol 1,4,5-trisphosphate (Ins 1,4,5P3) and arrhythmias. The present study investigates the effect of endothelin-1 on these responses.

Methods and Results—Ins 1,4,5P3 generation was quantified by use of [3H] labeling and high-performance liquid chromatography as well as by mass analysis. Twenty minutes of global ischemia followed by 2 minutes of reperfusion increased [3H]Ins 1,4,5P3 from 2828±265 to 5033±650 cpm/g tissue in the presence of thrombin 2.5 IU/mL and to 4561±286 cpm/g tissue in response to release of norepinephrine (n=4, P<0.01) in both cases. Reperfusion in the presence of endothelin-1 alone caused no change in Ins 1,4,5P3 (2762±240 cpm/g tissue), but when added together with thrombin or norepinephrine, endothelin-1 reduced the Ins 1,4,5P3 responses to 2313±197 and 1764±168 cpm/g tissue, respectively (n=4, P<0.01 in both cases). Similar inhibitory interactions between endothelin-1 10 nmol/L and thrombin 2.5 IU/mL were observed under normoxic conditions in nonperfused ventricle, eliminating the possibility that excessive vasoconstriction was responsible. In parallel studies, endothelin-1 suppressed the development of reperfusion arrhythmias initiated by either thrombin (ventricular fibrillation, 75% to 39%, n=16 to 18) or norepinephrine (83% to 8%, n=12 to 22) (P<0.01 in both cases).

Conclusions—Inhibition of Ins 1,4,5P3 generation during myocardial reperfusion by endothelin-1 represents a novel antiarrhythmic mechanism.


Key Words: inositol trisphosphate • arrhythmias • endothelin • thrombin • receptors, adrenergic, alpha




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
D. L. Brutsaert
Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity
Physiol Rev, January 1, 2003; 83(1): 59 - 115.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. T. Goodwin, R. T. Smolenski, C. C. Gray, J. Jayakumar, M. Amrani, and M. H. Yacoub
Role of endogenous endothelin on coronary reflow after cardioplegic arrest
J. Thorac. Cardiovasc. Surg., December 1, 2001; 122(6): 1167 - 1173.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Vassort
Adenosine 5'-Triphosphate: a P2-Purinergic Agonist in the Myocardium
Physiol Rev, April 1, 2001; 81(2): 767 - 806.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Duru, M. Barton, T. F. Luscher, and R. Candinas
Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs?
Cardiovasc Res, February 1, 2001; 49(2): 272 - 280.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Matkovich and E. A. Woodcock
Ca2+-activated but Not G Protein-mediated Inositol Phosphate Responses in Rat Neonatal Cardiomyocytes Involve Inositol 1,4,5-Trisphosphate Generation
J. Biol. Chem., April 6, 2000; 275(15): 10845 - 10850.
[Abstract] [Full Text] [PDF]